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Composite pheochromocytoma/paraganglioma is a rare tumor with elements of pheochromocytoma/
paraganglioma and neurogenic tumor. Most were located in the adrenal glands, and extra-adrenal composite
pheochromocytoma is extremely rare. Only 4 cases in the retroperitoneum have been described in the online
database PUBMED. Here, we report a case of retroperitoneal extra-adrenal composite pheochromocytoma and
review the related literature.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1700539911908679
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Pheochromocytoma arising from outside the adrenal
glands is commonly called paraganglioma. But when it
occurs below the diaphragm, in the organ of Zuckerkandl
or retroperitoneum, it is also called extra-adrenal pheo-
chromocytoma [1]. Extra-adrenal pheochromocytoma is
uncommon, and extra-adrenal composite pheochromocy-
toma is extremely rare. Only 11 extra-adrenal cases have
been reported in the literature and 4 of which in the
retroperitoneum [2-7]. Most of these rare tumors were
compounded with ganglioneuroma. Some of them were
functional, resulting in increased level of catechol-
amines and associated symptoms such as hypertension
[6]. However, this case we reported was nonfunctional
and the fifth case of composite pheochromocytoma-
ganglioneuroma in the retroperitoneum, with the follow-
ing objectives: 1) to improve understanding of the variable
clinical presentation of composite pheochromocytoma-
ganglioneuroma, and 2) to identify histomorphological* Correspondence: caili2004043@yahoo.com.cn
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reproduction in any medium, provided the orand immunohistochemical features of composite pheo-
chromocytoma-ganglioneuroma.Case history
Case presentation
A 52-year-old Chinese woman was admitted to our
hospital for watery diarrhea and febricity for one day,
palpitation and debilitation for 6 hours. She had a history
of immunologic thrombocytopenic purpura, femoral head
necrosis and connective tissue disease. But she had not
complained of headache and had no history of hyper-
tension. The sonography of abdomen showed a space-
occupying lesion in caput pancreatis. But the magnetic
resonance imaging (MRI) (Figure 1) confirmed a 6 cm het-
erogeneous right retroperitoneal mass, with enhancing
rim and central low attenuation on the enhancement
scanning of T1-weighted images. The inferior caval vein
and portal vein were deformed by the compression of the
mass. ST-T abnormalities were seen on the electro-
cardiogram. The serum carbohydrate antigen 19–9 and
carcinoembryonic antigen were normal. And troponin I
was 4.4 ug/l, creatine kinase-MB was 15.3 ug/l. During the
laparotomy, the retroperitoneal mass lied at the left
posterior to hepatoduodenal ligament, right of aorta
abdominalis, which compressed forward the inferior cavalThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The enhancement scanning of transsected T1-
weighted images showed a 6 cm heterogeneous right
retroperitoneal mass, with great signal intensity on the edge
and weaker in the center, compressing the inferior caval vein
and the portal vein.
Figure 3 The tumor was composed of two distinct patterns:
pheochromocytoma and ganglioneuroma (H&E×40).
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http://www.diagnosticpathology.org/content/8/1/63vein and left renal vein. Then the patient underwent
mass resection for biopsy. The findings on pathology
examination were consistent with retroperitoneal compos-
ite pheochromocytoma-ganglioneuroma. The patient re-
covered well after tumor resection, without adjuvant
chemotherapy or radiotherapy. And Long-term follow-up
was suggested.
Pathologic findings
Grossly, the external surface of soft solid tumor was
smooth and well-encapsulated. The tumor measured
6 cm × 5 cm× 4 cm. The cut surface was soft and dark tan
with focal gray-yellow (Figure 2). Histologically, the tumor
was composed of two distinct patterns (Figures 3, 4, 5),
stained with hematoxylin-eosin (H&E). One pattern was
consistent with pheochromocytoma. It was composed ofFigure 2 Macroscopic findings: the cut surface of the tumor
was soft and dark tan with focal gray-yellow.nests of large, polygonal and pleomorphic cells with
granular and basophilic to amphophilic cytoplasm. And
the nuclei were round to oval with prominent nucleoli.
The nests were separated by spindle-shaped, elongated
cells (Schwann cells) (Figure 4). The other pattern
consisted of ganglion cells embedded in the Schwann cell
which was consistent with ganglioneuroma (Figure 5).
The two components were separate but irregularly
merged from one into the other. The necrosis or mitotic
figures were not found. But in some focal areas, some
small round primitive neuroblastic-like cells were present.
Immunohistochemistrical staining was performed by the
streptavidin-biotin-peroxidase method and diaminoben-
zidine as chromogen. Primary antibodies used in this study
were prediluted and bought from Maixin Biocorpration,
China. Appropriate positive and negative controls were
performed. Both the pheochromocytoma component
and ganglioneuroma component of the tumor wereFigure 4 The pheochromocytoma pattern of the composite
tumor (H&E×100).
Figure 5 The ganglioneuroma pattern of the composite
tumor (H&E×100).
Figure 7 The ganglion cells were strongly positive for
neurofilament, but the chromaffin cells were negative for
neurofilament (Envision×100).
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synaptophysin (Syn) and Vimintin(Vim). The chromaffin
cells were strongly positive for chromogranin A and nega-
tive for neurofilament (Figures 6, 7). However, the ganglion
cells were negative or weakly positive for chromogranin
A, but positive for neurofilament (Figures 6, 7). The
sustentacular cells of the pheochromocytoma component
and the schwannian cells of ganglioneuroma component
showed characteristic staining of S100 (Figure 8).
Discussion
Composite pheochromocytoma/paraganglioma is a rare
tumor that typically combines features of pheochromocy-
toma or paraganglioma with those of ganglioneuroma,
ganglioneuroblastoma, neuroblastoma, peripheral nerve
sheath tumour or neuroendocrine carcinoma [8]. Fewer
than 70 cases have been reported in the medical literature.Figure 6 The chromaffin cells were strongly positive for
chromogranin A, but the ganglion cells were negative or
weakly positive for chromogranin A (Envision×100).Most were located in the adrenal glands, and extra-adrenal
composite pheochromocytoma/paraganglioma was repor-
ted occasionally [9]. To the best of our knowledge, only 11
extra-adrenal cases have been reported, located in the
urinary bladder (6 cases) [2], the retroperitoneum (4 cases)
[3,4,6,7], and the cauda equine (1 case) [5], respectively.
About 71% of composite pheochromocytoma/paragan-
glioma coexisted with ganglioneuroma (Pheo-GN). The pa-
tients ranged from 5 to 82 years old, with the majority in
the age range of 40 to 60 years, and these tumors occurred
with approximately equal frequency in male and female
subjects [9]. The 4 patients with composite pheochromocy-
toma/paraganglioma in the retroperitoneum were older
than 40 years of age (range 41-63 years). Males and females
are equally affected. All of which coexisted withFigure 8 The sustentacular cells of the pheochromocytoma
component and the schwannian cells of ganglioneuroma
component showed characteristic staining of
S100 (Envision×40).
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the rest in China and USA (Table 1).
Like ordinary pheochromocytoma/paraganglioma, most
cases of composite pheochromocytoma/paraganglioma
were functional, with increased level of catecholamines or
corticotropin-releasing hormone (CRH) [10] or their me-
tabolites or whatever, and over 62% of the patients were
also hypertensive [3]. Embryologically, both the chromaf-
fin cells of the pheochromocytoma and the ganglion cells
of the ganglioneuroma are derived from neural crest cells
and migrate to somatic areas [9]. These cells have the
potential to produce many peptide hormones and biogenic
amines [11]. It is apparent that the composite tumor of
pheochromocytoma and ganglioneuroma may display
symptoms referable to hormonal hypersecretion by either
portion of the tumor, such as headache, palpitation, and
excessive perspiration. And Mahajan et al. [11] described
watery diarrhea attributable to increased secretion of
vasoactive intestinal peptide (VIP) in some cases. Both
the phaeochromocytoma and non phaeochromocytoma
components were capable of secreting VIP. This further
supported its common derivation. In the 4 cases of retro-
peritoneal composite pheochromocytoma/paraganglioma,
only 1 case was found functional evidence, such as
hypertension, headache or palpitation, preoperatively
[6]. Another case was reported that the ganglion cells in
ganglioneuroma were positive for VIP in immunohisto-
chemical examination [7]. In our case, the patient had
no hypertension or any classic symptoms of pheochro-
mocytoma. She only complained of palpitation and
debilitation. However, watery diarrhea may be caused by
the composite tumor through secreting VIP.
The composite pheochromocytomas/paragangliomas
were often associated with familial neoplasm syndromes
such as neurofibromatosis type 1 (NF1) [12] or multiple
endocrine neoplasia type 2A (MEN 2A) [13]. However, as
in our case, association of composite tumor with NF1 or
MEN 2A had not been reported in the 4 cases of retroperi-
toneal composite pheochromocytoma/paraganglioma.
The size of composite pheochromocytoma/paraganglioma
ranged from 1 to 35 cm, with the average being 4 to 6 cm.Table 1 Clinical and pathologic features in four cases of retro
Age/
Sex
Clinical Features Syndrome Tumor
Size(cm)
His
48/M NA NA NA PH
41/F Hypertension,palpitation,headache,
retroperitoneal mass
None 4.4 × 4 × 2 PH
63/F retroperitoneal mass None 6.5 × 5 × 3 PA
50/M retroperitoneal mass None 4.5 × 4 ×
2.5
PA
NA, not available; PH, pheochromocytoma; GN, ganglioneuroma; PA, paragangliomaAnd the size of which in the retroperitoneum ranged from
2.0 to 6.5 cm in diameter. Grossly, composite pheochro-
mocytomas/paragangliomas were usually similar to typical
pheochromocytomas. So the composite phenotype was
generally detected during histological examination. Gross
examination of the tumors usually revealed patchy, pale
areas corresponding to ganglioneuroma or necrotic and
hemorrhagic areas of ganglioneuroblastoma sometimes
[14]. The different cell populations were admixed or ar-
ranged in a patchwork as a collision tumor. The presence
of stromal features hinted the mixed phenotype. In our
case, the tumors were traversed by bundles of spindle cells
that shown containing Schwann cells and axons immu-
nohistochemically, and there were also patchy areas with
prominent sustentacular cells.
Immunohistochemically, the individual components of
these tumors resemble their normal counterparts or pure
tumors of the same type. Both Chromogranin A and
synaptophysin were strongly and diffusely positive in the
pheochromocytoma/paraganglioma cells [15]. In contrast,
staining was weak or focal in neuroblasts and mature
neurons. This difference was helpful in identifying foci of
neuroblastoma in composite tumors and for distinguishing
neuroblasts from mature pheochromocytoma cells of the
same size. Immunoreactive catecholamine-synthesizing
enzymes such as tyrosine hydroxylase (TH) and pheny-
lethanolamine N-methyltransferase (PNMT) were help-
ful to identify catecholamine-producing cells and infer
the specific catecholamines they produced [9]. In
addition, staining for S-100 protein identifed Schwann
cells and sustentacular cells. While staining for neuro-
filament proteins aided in identification of axon-like
processes. Immunoreactive VIP was found predomin-
antly in neuronal components of the composite tumors
with watery diarrhea-hypokalemia-achlorhydria syndrome.
However, VIP was also positive in phaeochromocytoma
cells occasionally [11,16].
No genetic abnormalities were found to distinguish
composite tumors from pure pheochromocytomas or
paragangliomas. Comstock et al. [17] reported that neither
composite pheochromocytomas nor classic pheochro-peritoneal composite pheochromocytoma
topathology Outcome Reference
(country)
-GN NA Yoshimi et al.
(5),1992(Japan)








-GN Tumorfree and in good condition
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(50%) of 10 neuroblastomas showed significant N-myc
amplification. These findings suggested that N-myc ampli-
fication in the composite pheochromocytoma with neu-
roblastic elements may imply worse outcome.
It was difficult to predict the biologic behavior of com-
posite tumors. The prognosis associated with composite
phaeochromocytoma-ganglioneuroma was variable. Me-
tastatic lesions from these tumors were almost derived
from the neural component; however, pheochromocy-
toma metastasizing as a single entity or in conjunction
with the malignant neural component was found in
some uncommon cases [16]. Only 1 case of phaeo-
chromocytoma-ganglioneuroma had been reported with
liver metastatic lesions at the time of autopsy [16]. In
the 4 cases of retroperitoneal composite phaeochro-
mocytoma-ganglioneuroma, the invasion of the inferior
vena cava and of the right renal artery in one case was
concerned about the malignant potential. But the patient
was asymptomatic and tumorfree after one year of follow
up [6]. And the malignant features such as infiltration or
metastasis were not found in the other cases. In our case,
the presentation of some small round primitive neuroblastic-
like cells in some focally areas maybe imply malignant po-
tentiality prognosis. However, the patient was tumorfree
for 24 months after surgery.
Composite pheochromocytoma/paraganglioma-ganglio-
neuroma were treated in principle by surgical resection, as
most of which were benign [2,9]. And adequate clinical follow-
up was advised for the potentially malignant neoplasms.
In conclusion, composite pheochromocytomas/paragan-
gliomas were rare tumors most located in adrenal glands.
And extra-adrenal composite pheochromocytomas/paragan-
gliomas were extremely rare. The clinical features were simi-
lar to ordinary pheochromocytoma, but little was known
about the biologic behavior, outcome or molecular genetic
profile. Herein, we described a retroperitoneal composite
pheochromocytoma coexisted with ganglioneuroma and
reviewed the related literature. Although composite pheo-
chromocytoma -ganglioneuroma in the retroperitoneum
was not common, the possibility of a neuroen-docrine
tumor should be considered in the differential diagnosis of
a retroperitoneal mass, especially in patient with hyperten-
sion or watery diarrhea.
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